Digest Network Come funziona
Network
/
Società
Ve
Non verificato

Veradermics, Incorporated

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteSanità

11 comunicati stampa

Guarda tutti i comunicati
14/05/2026
Eventi
Fiere
Biotecnologia
Farmaceutica
Salute
Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
12/05/2026
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
30/04/2026
Finanza
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Veradermics Announces Pricing of Upsized Public Offering and Private Placement
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
27/04/2026
Finanza
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Veradermics Announces Launch of Public Offering
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
26/04/2026
Web e Social Network
Telefonia e Varie
Scienza
Biotecnologia
Farmaceutica
Sanità
Salute
Medicina - Varie
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
30/03/2026
Mercato azionario
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
18/03/2026
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Eventi
Industria
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
03/03/2026
Eventi
Biotecnologia
Sanità
Salute
Farmaceutica
Medicina - Varie
Veradermics to Participate in Upcoming March Investor Conferences
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
09/02/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Cardiologia
Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0
05/02/2026
Associazioni/Professionisti
Salute
Finanza
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Titoli e azioni
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
Fonte
Veradermics, Incorporated
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0